Goldstein B P, Ripamonti I F, Bolzoni G, Carniti G, Arioli V
Antimicrob Agents Chemother. 1979 Dec;16(6):736-42. doi: 10.1128/AAC.16.6.736.
The bactericidal effect of a combination of rifampin (Ramp) and trimethoprim (Tmp) was studied using dense cultures of test organisms, including some urinary pathogens, growing in human urine. Drug concentrations used were similar to those attainable in human urine. The combination was more effective than the individual drugs and than a combination of Tmp plus sulfamethoxazole (Smx). Tmp was bactericidal in urine and blocked the emergence of Ramp-resistant bacteria. Ramp was responsible for most of the bactericidal action of the combination but also potentiated the bactericidal activity of Tmp. Ramp suppressed the selection of thy- (Tmp-resistant) bacteria. Under the experimental conditions, Smx+Tmp was not more bactericidal than Tmp alone for most of the test organisms, despite strong synergy between the two at subinhibitory concentrations.
利用在人尿中生长的包括一些尿路病原体在内的受试生物体的密集培养物,研究了利福平(Ramp)和甲氧苄啶(Tmp)联合使用的杀菌效果。所用药物浓度与人尿中可达到的浓度相似。该联合用药比单一药物以及Tmp加磺胺甲恶唑(Smx)的联合用药更有效。Tmp在尿液中具有杀菌作用,并阻止了耐Ramp细菌的出现。Ramp是联合用药中大部分杀菌作用的原因,但也增强了Tmp的杀菌活性。Ramp抑制了耐thy(耐Tmp)细菌的选择。在实验条件下,对于大多数受试生物体,Smx+Tmp并不比单独使用Tmp更具杀菌作用,尽管两者在亚抑菌浓度下有很强的协同作用。